# Gland Pharma Ltd (GLAND)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹2334
Day Change: +0.13%
52W High: ₹2164.4
52W Low: ₹1452.2
Market Cap: ₹35,212 Cr

## Valuation
P/E: 41.6
P/B: 3.68
EPS: ₹51.38
Book Value: ₹580.47
Dividend Yield: 0%

## Returns
1Y Return: 17.34%

## Profitability
ROE: 10.53%
ROCE: 18.05%
Debt/Equity: 0.03
Revenue Growth: 30.1%
Profit Growth: 96.4%
EBITDA Margin: 28.84%
Operating Margin: 27.82%

## About
Gland Pharma Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Gland Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 3 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:07.443Z
Price History Updated: 2026-05-18T22:58:11.996Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:11.996Z
Quant Updated: 2026-05-18T22:58:11.996Z
Sentiment Updated: 2026-05-18T22:58:11.996Z
Financials Status: current
Financials Updated: 2026-05-18T08:30:46.700Z
Financials Last Attempt: 2026-05-18T08:30:46.700Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2021)
Revenue: ₹2633 Cr
Operating Profit: ₹955 Cr (OPM 36%)
Net Profit: ₹773 Cr
Tax: ₹993 Cr

## Annual P&L History
Mar 2021: Rev ₹2633Cr | PAT ₹773Cr | OPM 36%
Mar 2022: Rev ₹3463Cr | PAT ₹997Cr | OPM 38%
Mar 2023: Rev ₹4401Cr | PAT ₹1212Cr | OPM 34%

## Balance Sheet (Mar 2021)
Total Assets: ₹4086 Cr
Total Liabilities: ₹4086 Cr
Borrowings: ₹5 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Srinivas  Sadu, Executive Chairman
- Ravi Shekhar Mitra, Chief Financial Officer
- Sampath Kumar Pallerlamudi, Company Secretary & Vice-President of Compliance & CSR
- Prasadha Rao Lysetti, Senior VP & Head of Operations
- Shriniwas P. Dange, Head of Investor Relations

---
Source: rupiya.io/stocks/gland
Disclaimer: For research and education only. Not investment advice.